Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Slide 1 - Annals of Internal Medicine
Transcript
From: Rituximab for Bone Lymphoma Ann Intern Med. 2001;134(12):1156-1157. doi:10.7326/0003-4819-134-12-200106190-00032 Figure Legend: Results of rituximab treatment for osseous non-Hodgkin lymphoma in a 58-year-old woman.top leftlarge arrowheadarrowtop rightarrowarrowheadsbottom leftbottom rightFive months after diagnosis, radiography ( ) showed permeative destruction of the right pubic bone and adjacent ischium ( ) and permeative destruction of the lateral aspect of the left ilium ( ) immediately superior to the left hip joint. When rituximab therapy was started, a computed tomography scan of the pubis ( ) showed nearly total destruction of the right inferior pubic ramus ( ) with an adjacent 4-cm soft tissue mass ( ). Twenty-two months after rituximab therapy, all previous areas of osseous destruction had healed on pelvic radiography ( ). Computed tomography ( ) showed resolution of the soft tissue mass and evidence of osseous healing. Date of download: 5/9/2017 Copyright © American College of Physicians. All rights reserved.
